Dimensional Fund Advisors’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
Dimensional Fund Advisors's DSGN Position: Q3 2026 in Review
Dimensional Fund Advisors increased its Design Therapeutics (DSGN) stake by 4.7% in Q3 2026, buying an estimated $454K and bringing the position to 727,567 shares worth $9.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2311.
Dimensional Fund Advisors first reported a position in DSGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $10.1M in Q2 2026. 96 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.
- Dimensional Fund Advisors held 727,567 shares of Design Therapeutics worth $9.15M as of Q3 2026.
- Dimensional Fund Advisors bought 32,824 Design Therapeutics shares in Q3 2026, an estimated $454K.
- Design Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2311 holding.
- Dimensional Fund Advisors first reported a position in Design Therapeutics in Q2 2022 and has held it in 17 quarters since.
- Dimensional Fund Advisors's Design Therapeutics position peaked at $10.1M in Q2 2026.
- 96 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.